Twists and turns in biomarker exploration

“There’s no standardization for cell-free DNA extraction, preparation, and storage,” says Dr. Martin Fleisher. “That’s a major failing. “That’s a major failing. Everybody has their own little method, which is not good.”

Read the full story »

Dr. Martin Fleisher

Carbapenem resistance:
advice from the frontline

“When there’s a carbapenem-resistant organism,” says Eileen Burd, PhD, “we use the Modified Hodge test to confirm.” Positive organisms are flagged in the computer to alert infection prevention staff and nurses on the floor to take proper precautions.

Read the full story »

Eileen Burd, PhD

Checklists 2015: signposts are clarity, consistency

The broadest changes this year involve quality terminology, says Gerald Hoeltge, MD, checklist commissioner and a member of the Checklists Committee. These revisions are a work in progress, but in this round they led to hundreds of changes in wording to make the use of important terms more precise and more consistent.

Read the full story »

Gerald Hoeltge, MD

Superbugs on scopes: how UCLA lab found the outbreak

Dr. Romney Humphries: “The carbapenemase that was present was an OXA-232,” which had been reported only once before in the U.S. “We really didn’t expect to find this,” she says.

Read the full story »

Hal Weiner

August 2015 Issue

Read, save, and print articles from the current issue.

Product Guides

Compare instruments and software systems.

Past Articles

List and summary of past articles from 2013–2015.

Past Departments

List and summary of past departments from 2013–2015.


New pathology lab products and industry news.

CAP TODAY Recommends

Right data can improve blood bank, transfusion service

August 6, 2015—An upcoming webinar aims to help participants recognize how timely data derived from electronic problem or deviation management can drive quality improvement initiatives. The webinar is sponsored by Nouvation. Register.

What’s in store for POC testing

July 31, 2015—A new white paper and webinar offered by Orchard Software outline the factors shaping the point-of-care testing market, the benefits and challenges POC tests offer for labs, and the potential for harnessing data from POC tests for use in analytics. Read the white paper.

The CPOE Lab Test: Utilization Opportunity

This editorial is brought to you through Roche’s Lab Leaders initiative.

AMP sees bright future for liquid biopsy

May 20, 2015—The Association for Molecular Pathology recently published a special article that provides a thorough overview of research to date on the minimally invasive “liquid biopsy” approaches to cancer diagnostics. Read it.

How breath tests can diagnose liver diseases

May 20, 2015—In a recent interview, Exalenz Bioscience CEO Larry Cohen discussed his company’s innovations in testing for H. Pylori and clinically significant portal hypertension with its BreathID test. Read it.

Roundtable discussions 2015:
The future of the lab in health care

April 6, 2015—In a collaborative effort to discuss the future of the laboratory in healthcare, Bob McGonnagle, Publisher of CAP Today, gathered with Orchard Software executives for a series of “round table discussions” on various topics surrounding the laboratory, informatics, analytics, and the future of healthcare. Listen now.

More CAP TODAY Recommends